Authors
Latest:
Noninvasive Neuromodulation for Essential Tremor: An Important Tool for Maintaining Independence at HomeNoninvasive neuromodulation with TAPS is a safe and effective tool that offers particular utility in the age of COVID-19 when other treatment options may be less accessible.
Latest:
Gene Therapy Shows Robust Activity for Duchenne Muscular DystrophyA novel gene therapy has demonstrated impressive early results in a small sample of 3 children with Duchenne muscular dystrophy.
Latest:
An Emerging Framework for Parkinson Disease TherapeuticsThe diagnosis of Parkinson disease may seem straightforward at first, requiring neurologists to rely on their eyes and hands, but the treatment process can present challenges for both physicians and patients.
Latest:
Effectiveness of Minimally Invasive Parafascicular Surgery in Intracerebral Hemorrhage: Andrew Russman, DOThe head of the Stroke Program and Medical Director of the Comprehensive Stroke Center at Cleveland Clinic provided perspective on the ENRICH trial, the first positive surgical trial for intracerebral hemorrhage. [WATCH TIME: 5 minutes]
Latest:
Peter Nakaji, MD: The State of Science for Epilepsy SurgeryThe chair of the Department of Neurosurgery at Banner-University Medical Center discusses the current state of the science being done in the realm of epilepsy surgery.
Latest:
Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical CareThe postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.
Latest:
Naeem Khan, MD: Ticagrelor Shines in Phase 3 THALES TrialThe vice president of AstraZeneca’s Cardiovascular and Metabolic Diseases Portfolio detailed the results from the phase 3 THALES trial, and where ticagrelor stands among other FDA approved stroke treatments.
Latest:
Recent Advances and Emerging Therapies in the Management of Alzheimer's DiseaseIn this episode of MEDcast, expert geriatric psychiatrist and neurologist delve into the recent advances in the treatment of Alzheimer’s disease. We will discuss treatments that are on the cusp of FDA approval and others that are coming down the pipeline.
Latest:
Kathleen Hawker, MD: Clinical Findings for Satralizumab in Treating NMOSDThe group medical director of neuroscience at Genentech spoke to the findings recently presented at the 6th Annual Meeting of the European Academy of Neurology.
Latest:
Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s DiseaseDrs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.
Latest:
Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine TreatmentThe clinical professor of neurology at Albert Einstein College of Medicine spoke to the findings of the OVERCOME study, and how recent literature has suggested that improper prescriptions and medication use in migraine have been ongoing in spite of the current recommendations.
Latest:
Amy Sullivan, PsyD: Personalized Approach to Fatigue in Multiple SclerosisThe Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about how she approaches fatigue in MS from a behavioral standpoint.
Latest:
Jeff Waugh, MD, PhD: Viewing Striatal Injury More GranularlyDespite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.
Latest:
Emphasizing Shared Decision Making and Emerging Strategies in MS Treatment: Patricia K. Coyle, MDThe professor of neurology at Stony Brook University Medical Center discussed the significance of shared decision making in multiple sclerosis care and promising developments in treatment strategies. [WATCH TIME: 3 minutes]
Latest:
Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine SurgeryThe spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.
Latest:
Current and Future Landscape of Alzheimer Disease Treatment: Emergence of Disease Modifying TherapiesAfter years of failed drug development, the thoughts of disease-modifying therapies for Alzheimer disease are starting to become real.
Latest:
Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS TechnologyThe professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.
Latest:
Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic HeadacheMia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.
Latest:
Eugenia Trushina, PhD: Communication and Learning Through CollaborationFor the associate professor of neurology, learning, listening, and collaborating are the keys to improving the field of care.
Latest:
Narrowing Down Effective Medications, Classes of Treatments for Migraine: Chia-Chun Chiang, MDThe associate professor of neurology at Mayo Clinic Rochester discussed specific findings from a simultaneous comparison of migraine medications in which certain treatments and classes were more effective. [WATCH TIME: 3 minutes]
Latest:
The Potential of Blood Tests to Improve Screening and Monitoring in Alzheimer Disease Clinical Trials: Ronald C. Petersen, MD, PhDThe director of the Alzheimer’s Disease Research Center at Mayo Clinic detailed the current issues with access and affordability to critical biomarkers in the screening and monitoring of patients in Alzheimer disease trials. [WATCH TIME: 3 minutes]
Latest:
The Importance of a Globally Aligned, Standardized MRI Protocol for MSLeaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.
Latest:
Pimavanserin Safety Data and Future Research: Clive Ballard, MDClive Ballard, MD, spoke on the safety data of pimavanserin, which was presented at the 2021 AAIC meeting, held from July 26-30.
Latest:
Ari Green, MD, MCR: Remyelination in Multiple SclerosisThe medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.
